Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
- Conditions
- Ulcerative ColitisCrohn's DiseaseIBD
- Interventions
- Device: Multispectral Optoacoustic Tomography (MSOT)
- Registration Number
- NCT02622139
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Brief Summary
Monocentric, prospective interventional study to assess the degree of disease activity with a multispectral optoacoustic tomography (MSOT) handheld scanner in patients with Crohn's disease or ulcerative colitis.
- Detailed Description
The proposed study is designed as a pilot study to evaluate the usefulness of MSOT for the evaluation of disease activity in IBD patients. As current methods for the evaluation of intestinal inflammation in IBD have relevant restrictions, new, non-invasive, quantitative, and accurate modalities are urgently needed. In comparison to other techniques, MSOT provides relevant advantages such as non-invasive imaging, high spatial resolution (this is of special importance for the evaluation of the intestine, which can be only a few millimeters thick), and highly sensitive detection of specific molecules such as total hemoglobin or oxy- /deoxygenated hemoglobin. These advantages suggest MSOT as an outstanding technique for evaluating disease activity in IBD.
The proposed study incorporates nearly no risk for participating patients and might provide relevant data for more a more in depth analysis of MSOT for IBD diagnosis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 344
- Histological verified Crohn's disease or ulcerative colitis
- Age > 18 years
- Age < 18 years
- Mental retardation of the patient with restriction of general judgment and awareness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Multispectral Optoacoustic Tomography Multispectral Optoacoustic Tomography (MSOT) Multispectral Optoacoustic Tomography (MSOT) for the evaluation of disease activity in inflammatory bowel diseases (IBD)
- Primary Outcome Measures
Name Time Method Correlation of MSOT-data with sonographic parameters 12 month Correlation of MSOT-data with clinical activity scores of IBD 12 month
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Medical Department 1, University of Erlangen-Nürnberg
🇩🇪Erlangen, Bavaria, Germany